Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
1999 · PubMed · 300 citations
J
J. Moore
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
3.3K
Citations
17
h-index
21
i10-index
J. Moore is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes & Immunotherapy and Immune Responses. The author has an h-index of 17, co-authored 44 publications.
ORCID: 0000-0002-9124-8006Papers by this author
worksDelayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer
2023 · Annals of Surgery · 19 citations
https://doi.org/10.1097/sla.0000000000006028
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
2023 · European Radiology · 9 citations
https://doi.org/10.1007/s00330-023-09482-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat